Call for Abstract

34th Euro Congress on Neurologists and Psychiatrists, will be organized around the theme “Exploring the Intersection of Neurological and Psychiatric Disorders”

Euro Neuro 2025 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Neuro 2025

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Neuropsychiatric disorders and addiction to psychotropic substances are often intertwined, creating a complex cycle that negatively impacts mental health. Conditions like depression, anxiety, and schizophrenia can increase susceptibility to substance abuse, as individuals may self-medicate to cope. This bidirectional relationship leads to dual diagnosis, where both substance use disorders and mental health conditions are present. Effective treatment requires integrated care that addresses both the addiction and underlying psychiatric issues through medication, therapy, and support. 

  • Addiction Neuroscience
  • Comorbid Disorders
  • Addiction Stigma & Mental Health
  • Genetics of Addiction

Neurological disorders, stroke, and CNS injuries are serious health conditions affecting the brain, spinal cord, and nerves. Disorders like Alzheimer's, Parkinson's, Epilepsy and Multiple Sclerosis can impair cognitive, motor, and sensory functions due to genetic, infectious or degenerative causes. Stroke, caused by interrupted blood flow to the brain, leads to brain cell damage and deficits in movement, speech, and cognition. CNS injuries, often from trauma, can result in paralysis, cognitive impairments, or chronic pain.

Digital mental health interventions use technology to provide accessible support for mental health challenges. These tools include mobile apps, online therapy, virtual support groups, and digital CBT, offering convenient and often anonymous resources for managing conditions like anxiety and depression. They provide immediate support, track progress, and deliver personalized content, making mental health care more accessible, particularly for those in remote or underserved areas.

  • Tele psychiatry
  • E-Health in Cognitive Behavioural Therapy
  • Gamification in Mental Health Interventions
  • AI and Mental Health Diagnostics
  • Digital Tools for Depression & Anxiety

Forensic psychiatry is a specialized discipline that connects mental health with the legal system. It involves assessing and treating individuals involved in legal matters, such as criminal cases or civil disputes. Forensic psychiatrists evaluate mental competency, criminal responsibility, and provide expert testimony. They also work with offenders in correctional settings to address mental illness, reoffending risk, and rehabilitation. Forensic psychiatry ensures appropriate care while informing legal decisions with accurate psychological evaluations, balancing justice and mental health.

  • Psychopathy and Antisocial Behaviour
  • Ethics in Forensic Psychiatry
  • Juvenile Delinquency and Mental Health
  • Insanity Defense and Legal Implications
  • Mental Health and Criminal Behaviour

Recent developments in spine surgery have resulted in improved outcomes, reduced recovery periods, and enhanced patient safety. Minimally invasive techniques involve smaller incisions and minimize muscle disruption, resulting in faster recovery. Robotic-assisted surgery provides enhanced precision and accuracy for intricate procedures. Advances in spinal implants, such as 3D-printed devices and stem cell therapies, improve spinal fusion and regeneration. Image-guided navigation and intraoperative monitoring ensure safer surgeries by providing real-time feedback.

Neuroimmunology and neuroplasticity are interconnected fields that explore the ways in which the immune system and the nervous system interact and affect one another. Neuroimmunology explores how immune responses impact the brain and spinal cord. The immune system can influence brain function by releasing molecules that impact neurons, inflammation, or neurodegeneration. Neuroplasticity refers to the brain's ability to reorganize itself by forming new neural connections in response to injury, learning, or environmental changes, aiding recovery after damage. Together, these fields provide insights into brain healing and potential treatments for neurological disorders.

Autism Spectrum Disorder (ASD) and Paediatric Neurological Disorders significantly impact a child's cognitive, social, and behavioural development. ASD is a neurodevelopmental disorder defined by difficulties in communication, social interactions, and repetitive behaviors. Early diagnosis and interventions like behavioural therapy, speech therapy, and social skills training can improve outcomes. Paediatric neurological disorders, such as epilepsy, cerebral palsy, and developmental delays, affect the brain, spinal cord, and nerves, often requiring multidisciplinary treatment.

Bipolar disorder, anxiety disorders, and dementia are significant mental health conditions affecting emotional well-being, cognitive functioning, and quality of life. Bipolar disorder involves extreme mood swings between mania (elevated mood and high energy) and depression (sadness and fatigue), treated with mood stabilizers, antipsychotics, and therapy. Anxiety disorders, like generalized anxiety, panic, and social anxiety, cause excessive worry and fear, managed through cognitive-behavioural therapy, medication, and relaxation techniques. Dementia, including Alzheimer's, leads to memory and cognitive decline, with no cure but early diagnosis and treatments to manage symptoms. These disorders emphasize the importance of early intervention, personalized care, and ongoing support.

  • Managing Bipolar Disorder Across Lifespan
  • Psychopharmacology in Anxiety Disorders
  • Early Diagnosis of Dementia
  • Co-occurrence of Anxiety and Dementia
  • Mood Disorders and Cognitive Function
  • Biomarkers in Bipolar and Dementia

Molecular and cell biology in neurobiology studies the processes that regulate the structure, function, and communication of cells in the nervous system. It explores how molecules like neurotransmitters, proteins, and lipids influence neural development, function, and plasticity. Key topics include synaptic transmission, where signals are passed between neurons, and neurogenesis, the creation of new neurons. Researchers also examine how genetics and the environment affect brain function and neurological disorders. Advances in techniques like CRISPR and optogenetics are advancing our understanding of brain function and potential therapies for diseases like Alzheimer’s, Parkinson’s, and epilepsy.

Neuroinformatics and computational neuroscience combine data analysis, modeling, and computational techniques to understand the brain's structure, function, and neural networks. Neuroinformatics focuses on organizing and analysing large-scale data from brain imaging, genetics, and electrophysiology to uncover brain activity patterns and biomarkers for disorders. Computational neuroscience uses mathematical models to study how neural circuits process information, generate behaviour, and adapt. These fields offer insights into sensory processing, motor control, learning, and memory. Together, they enhance brain understanding and support new approaches in diagnosing and treating neurological diseases, playing a key role in personalized medicine and neurotechnology.

  • Neural Network Simulation
  • AI in Neurological Research
  • Neuroimaging Analysis Techniques
  • Neuroscientific Data Integration

Genetics and epigenetics are key in understanding neurodegenerative disorders and developing potential therapies. Genetics studies inherited DNA changes that increase the risk of conditions like Alzheimer's, Parkinson's, Huntington's, and ALS, with specific mutations, such as APOE ε4 in Alzheimer's, linked to higher risk. Epigenetics explores how environmental factors and lifestyle affect gene expression without changing DNA. Modifications like DNA methylation and histone changes can impact neural function, contributing to disease progression. Research into both genetic and epigenetic factors is offering new possibilities for early detection, targeted treatments, and prevention strategies for these conditions.

  • Hereditary Neurodegenerative Disorders
  • DNA Methylation in Neurodegeneration
  • Role of Inherited Mutations in ALS
  • Epigenetic Modifications in Alzheimer's
  • Gene Therapy for Neurodegenerative Diseases
  • Molecular Pathways in Parkinson’s Disease
  • Hereditary Neurodegenerative Disorders
  • Epigenetic Regulation of Brain Aging
  • Genetic Risk Factors for Dementia

Neuroimaging and neuroradiology are vital in neuroscience and medicine, providing detailed insights into the brain and CNS. Neuroimaging includes techniques like fMRI and PET for observing brain activity, and MRI and CT for high-resolution structural images, aiding in the diagnosis of conditions like tumours, strokes, and neurodegenerative diseases. Neuroradiology, a radiology subspecialty, involves interpreting neuroimaging data for accurate diagnosis, treatment planning, and monitoring neurological disorders. Advanced imaging helps detect brain lesions, vascular malformations, and neurodegeneration. Together, these fields have transformed the understanding, diagnosis, and treatment of neurological diseases through non-invasive methods.

Neurolinguistics is the study of how the brain processes, produces, and understands language, combining neuroscience, linguistics, psychology, and cognitive science. It examines how different brain regions are involved in language functions like speaking, listening, reading, and writing. Key areas of study include the impact of brain damage (e.g., from stroke) on language abilities and how linguistic processing occurs in healthy individuals. Research has identified areas such as Broca's area (responsible for speech production) and Wernicke's area (involved in language comprehension). Neurolinguistics also explores language acquisition, multilingualism, and language disorders like aphasia and dyslexia, advancing our understanding of the brain's language mechanisms.

Drugs, including prescription medications, recreational substances, and alcohol, can significantly impact the nervous system by altering brain function, behaviour, and neurological health. Psychoactive substances interact with neurotransmitters, affecting mood, cognition, and perception. Stimulants like cocaine increase dopamine levels, leading to euphoria and potential addiction, while depressants like alcohol enhance GABA activity, inducing relaxation. Opioids reduce pain but carry risks like addiction and respiratory depression. Long-term drug use can cause structural and functional changes in the brain, contributing to neurological disorders such as addiction, memory loss, and cognitive decline.

  • Drugs and Brain Receptors
  • Neurotoxic Effects of Drugs
  • Psychotropic Drugs and Mental Health
  • Drug-Induced Neuroplasticity
  • Opioids and the Nervous System
  • Drugs in Neurodegenerative Diseases
  • CNS Drug Delivery Systems

Brain-Computer Interfaces (BCIs) and neurobiotechnology are advancing fields that connect the brain to technology, with significant potential in medical treatments and human-computer interactions. BCIs allow direct communication between the brain and external devices, benefiting those with neurological impairments by enabling control of prosthetics or communication through brain signals. Neurobiotechnology, which includes BCIs, focuses on developing technologies to diagnose and treat brain disorders, such as gene editing, neurostimulation, and nanotechnology. These innovations aim to repair neural damage, enhance brain function, and treat conditions like Parkinson’s, epilepsy, and Alzheimer’s, revolutionizing both neurological treatments and human-machine interaction.

Non-invasive neuromodulation involves techniques that alter brain activity without surgery or implantation, offering a safe treatment for neurological and psychiatric disorders. Methods like transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) use magnetic fields or electrical currents to stimulate specific brain areas, helping conditions like depression, anxiety, chronic pain, and cognitive impairments. These therapies avoid the risks of invasive procedures and can be administered in clinical settings or at home. By restoring balance to disrupted neural circuits, non-invasive neuromodulation provides an alternative or complement to traditional treatments like medication and psychotherapy.

Advances in neurogenetics are enhancing our understanding of the genetic causes of neurological and psychiatric disorders. By identifying genes linked to conditions like Alzheimer's, Parkinson's, epilepsy, and autism, researchers are uncovering the molecular mechanisms behind brain function and dysfunction. Technologies like genome-wide association studies (GWAS), CRISPR, and next-generation sequencing enable precise exploration of complex disorders. These advances improve early diagnosis, risk prediction, and personalized medicine, tailoring treatments to an individual’s genetics. Neurogenetics also holds promise for developing gene therapies to address genetic mutations, potentially revolutionizing the prevention, diagnosis, and treatment of neurological diseases.

Epilepsy genetics and epileptology are interrelated fields focused on the genetic causes and clinical management of epilepsy, a disorder marked by recurrent seizures. Epilepsy genetics identifies mutations in genes related to ion channels and neurotransmitter receptors that disrupt brain activity and trigger seizures, particularly in childhood-onset epilepsy. Advances in genetic testing, like next-generation sequencing, improve diagnosis and understanding of the disorder's mechanisms. Epileptology involves the study, diagnosis, and treatment of epilepsy, using clinical expertise, neuroimaging, and genetics to develop personalized treatment plans, including medications, surgery, or neuromodulation. Together, these fields are enhancing epilepsy care and outcomes.

Neurodevelopmental diseases, neuroplasticity, and rehabilitation are interconnected in managing conditions affecting the developing brain. Neurodevelopmental diseases, like autism, cerebral palsy, and intellectual disabilities, result from abnormal brain development and cause challenges in motor, communication, and cognitive skills. Neuroplasticity, the brain's ability to reorganize and adapt, is key to recovery, allowing the brain to compensate for lost functions. Rehabilitation therapies, including physical, speech, and occupational therapy, stimulate neuroplasticity to promote functional recovery and improve quality of life. Early intervention and ongoing support enhance neural adaptability, helping individuals maximize their potential and achieve independence.

Neuro-oncology is a medical field focused on diagnosing and treating cancers of the nervous system, including the brain, spinal cord, and peripheral nerves. It covers a variety of tumours, such as gliomas, meningiomas, and metastatic brain tumours. This field involves a multidisciplinary approach with neurosurgeons, oncologists, and radiologists working together. Advances in neuro-oncology have improved diagnostics through advanced imaging and molecular profiling, leading to personalized treatment plans. Treatment options include surgery, radiation, chemotherapy, and emerging therapies like immunotherapy and gene therapy. Ongoing research continues to improve survival rates and quality of life for patients with neurological cancers.

  • Brain Tumour Genetics
  • Advances in Glioma Treatment
  • Paediatric Brain Tumours
  • Immunotherapy in Neurooncology
  • Radiation Therapy in Neurooncology
  • Targeted Therapy in Brain Tumours

Neuropsychiatric genetics studies the genetic factors contributing to mental health and neurological disorders. It focuses on identifying genes and mutations linked to conditions like schizophrenia, bipolar disorder, depression, autism, and Alzheimer’s disease. Advances in genetic research, including GWAS and next-generation sequencing, have revealed complex genetic networks affecting brain function and behaviour. These findings help understand how genetic predispositions and environmental factors interact to increase the risk of neuropsychiatric conditions. Neuropsychiatric genetics also enables personalized medicine, tailoring treatments to an individual's genetic makeup, with the potential to improve diagnosis, treatment, and prevention of these disorders.

Neuromuscular disorders affect the muscles and nerves that control them, causing weakness, coordination loss, and impaired movement. Conditions like ALS, muscular dystrophies, myasthenia gravis, and peripheral neuropathies disrupt nerve-muscle communication, leading to muscle weakness and, in severe cases, paralysis. These disorders can be caused by genetic mutations, autoimmune responses, infections, or injuries. Advances in genetic research and diagnostic tools, like genetic testing and EMG, have improved diagnosis and intervention. While cures are limited, treatments such as physical therapy, medications, and emerging therapies like gene or stem cell treatments offer hope for slowing progression and improving quality of life.

  • Amyotrophic Lateral Sclerosis (ALS) Genetics
  • Peripheral Neuropathies
  • Spinal Muscular Atrophy
  • Mitochondrial Myopathies

Inherited neurological syndromes are genetic disorders that affect the nervous system, causing various symptoms and impairments. Conditions like Huntington's disease, Charcot-Marie-Tooth disease and Friedreich's ataxia are examples, each resulting from mutations that disrupt brain function, motor skills, and sensory processing. These syndromes can appear at different life stages, with some evident in childhood and others in adulthood. Genetic testing helps identify mutations for early diagnosis and family planning.

  • Genetic Modelling for Drug Discovery
  • Genetic Risk Factors for Neurodegeneration
  • Gene Therapy in Neurological Disorders
  • Neurogenetics in Psychiatric Disorders

Inherited neurological syndromes are genetic disorders that affect the nervous system, caused by mutations in specific genes. These conditions, like Huntington's disease, Charcot-Marie-Tooth disease, and Friedreich's ataxia, lead to symptoms such as motor dysfunction, cognitive decline, muscle weakness, and sensory loss. Symptoms can appear at different stages of life, from childhood to adulthood. Early diagnosis through genetic testing is essential for managing these conditions and improving family planning.

Neuroethics and genetic research explore the ethical, legal, and social implications of advances in neuroscience and genetics, particularly regarding brain understanding and manipulation. As genetic research uncovers the causes of neurological disorders, concerns about privacy, consent, and genetic discrimination grow, especially with predictive testing for conditions like Alzheimer's or Huntington's disease. Ethical dilemmas also arise with neurotechnologies and genetic therapies, such as cognitive enhancement or brain modification, raising questions about fairness and autonomy. Neuroethics addresses the risks of interventions like gene editing and stem cell therapies, emphasizing the need to balance scientific progress with ethical responsibility to protect individual rights.

Neurogenetic counselling and patient care are key to managing genetic neurological disorders, helping individuals and families understand the genetic basis and implications of conditions like Huntington's disease and ataxia. Genetic counsellors provide information on inheritance patterns, risks, and testing options, while addressing emotional challenges related to uncertainty about prognosis. They work with neurologists and other specialists in a multidisciplinary approach to offer personalized care, focusing on symptom management and disease progression. By combining genetic insights with supportive care, neurogenetic counselling aids individuals in making informed decisions and navigating the complexities of living with genetic neurological conditions.

  • Psychosocial Impact of Genetic Testing
  • Genetic Counselling for Neurodegenerative Disorders
  • Counselling for Paediatric Neurological Disorders